Systemic inflammation alters the inflammatory response in experimental lipopolysaccharide-induced meningitis

Clinical and Experimental Immunology

Volumn 147, Issue 1, 2007, Pages 112-119

  O'Reilly, T ^a   Ostergaard C ^b   Vaxelaire, J ^a   Zak, O ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Endotoxaemia; Inflammation; Leucocytes; Lipopolysaccharide; Meningitis

Indexed keywords

LIPOPOLYSACCHARIDE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MECHANISM; ENDOTOXEMIA; ESCHERICHIA COLI; EXPERIMENTAL MODEL; INFLAMMATION; LEUKOCYTE; LEUKOCYTOSIS; MALE; MENINGITIS; NEUTROPENIA; NONHUMAN; PLEOCYTOSIS; PRIORITY JOURNAL; RABBIT; SUBARACHNOID SPACE;

ANIMALS; CEREBROSPINAL FLUID; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENDOTOXEMIA; ESCHERICHIA COLI; INJECTIONS; INJECTIONS, INTRAVENOUS; LEUKOCYTE COUNT; LIPOPOLYSACCHARIDES; MALE; MENINGITIS, BACTERIAL; MODELS, ANIMAL; RABBITS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33845495922     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03255.x     Document Type: Article

References (55)

1. Scheld WM, Koedel U, Nathan B, Pfister HW. Pathophysiology of bacterial meningitis: mechanism (s) of neuronal injury. J Infect Dis 2002; 186 (Suppl. 2):S225-33.
2. Tuomanen E. Entry of pathogens into the central nervous system. FEMS Microbiol Rev 1996; 18:289-99.
3. Moxon ER. Molecular basis of invasive Haemophilus influenzae type b disease. J Infect Dis 1992; 165 (Suppl. 1):S77-81.
4. Scheld WM, Park TS, Dacey RG, Winn HR, Jane JA, Sande MA. Clearance of bacteria from cerebrospinal fluid to blood in experimental meningitis. Infect Immun 1979; 24:102-5.
5. Brandtzaeg P, Kierulf P, Gaustad P et al. Plasma endotoxin as a predictor of multiple organ failure and death in systematic meningococcal diseases. J Infect Dis 1989; 159:195-204.
6. Brandtzaeg P, Ovsteboo R, Kierulf P. Compartmentalization of lipopolysaccharide production correlates with clinical presentation in meningococcal disease. J Infect Dis 1992; 166:650-2.
7. Feldman WE. Relation of the concentrations of bacteria and bacterial antigen in cerebrospinal fluid to prognosis in patients with bacterial meningitis. Med Intell 1977; 296:433-5.
8. Nau R, Bruck W. Neuronal injury in bacterial meningitis: mechanisms and implications for therapy. Trends Neurosci 2002; 25:38-45.
9. Kim KS, Wass CA, Cross AS, Opal SM. Modulation of blood-brain barrier permeability by tumor necrosis factor and antibody to tumor necrosis factor in the rat. Lymphokine Cytokine Res 1992; 11:293-8.
10. Kim KS, Wass CA, Cross AS. Blood-brain barrier permeability during the development of experimental bacterial meningitis in the rat. Exp Neurol 1997; 145:253-7.
11. Rooney P, Bilbe G, Zak O, O'Reilly T. Dexamethasone treatment of lipopolysaccharide-induced meningitis in rabbits that mimics magnification of inflammation following antibiotic therapy. J Med Microbiol 1995; 43:37-44.
12. Saez-Llorens X, Jafari HS, Severien C et al. Enhanced attenuation of meningeal inflammation and brain edema by concomitant administration of anti-CD18 monoclonal antibodies and dexamethasone in experimental Haemophilus meningitis. J Clin Invest 1991; 88:2003-11.
13. Syrogiannopoulos GA, Hansen EJ, Erwin AL et al. Haemophilus influenzae type b lipooligosaccharide induces meningeal inflammation. J Infect Dis 1988; 157:237-44.
14. Wispelwey B, Lesse AJ, Hansen EJ, Scheld WM. Haemophilus influenzae lipopolysaccharide-induced blood-brain barrier permeability during experimental meningitis in the rat. J Clin Invest 1988; 82:1339-46.
15. Burroughs M, Cabellos C, Prasad S, Tuomanen E. Bacterial components and the pathophysiology of injury to the blood-brain barrier: does cell wall add to the effects of endotoxin in gramnegative meningitis? J Infect Dis 1992; 165 (Suppl. 1):S82-5.
16. Mertsola J, Kennedy WA, Waagner D et al. Endotoxin concentrations in cerebrospinal fluid correlate with clinical severity and neurologic outcome of Haemophilus influenzae type B meningitis. Am J Dis Child 1991; 145:1099-103.
17. Østergaard C, O'Reilly T, Brandt C, Frimodt-Møller N, Lundgren JD. The influence of the blood bacterial load on the meningeal inflammatory response in Streptococcus pneumoniae meningitis. BMC Infect Dis 2006; 6:1-7.
18. Brandtzaeg P, Halstensen A, Kierulf P, Espevik T, Waage A. Molecular mechanisms in the compartmentalized inflammatory response presenting as meningococcal meningitis or septic shock. Microb Pathog 1992; 13:423-31.
19. Wagner JG, Roth RA. Neutrophil migration during endotoxaemia. J Leukoc Biol 1999; 66:10-24.
20. Bannerman DD, Goldblum SE. Mechanisms of bacterial lipopolysaccharide- induced endothelial apoptosis. Am J Physiol Lung Cell Mol Physiol 2003; 284:L899-914.
21. Wagner JG, Harkema JR, Roth RA. Pulmonary leukostasis and the inhibition of airway neutrophil recruitment are early events in the endotoxemic rat. Shock 2002; 17:151-8.
22. Rosenbaum JT, Hartiala KT, Webster RO, Howes EL Jr, Goldstein IM. Antiinflammatory effects of endotoxin. Inhibition of rabbit polymorphonuclear leukocyte responses to complement (C5)-derived peptides in vivo and in vitro. Am J Pathol 1983; 113:291-9.
23. Dacey RG, Sande MA. Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives. Antimicrob Agents Chemother 1974; 6:437-41.
24. Spector R, Lorenzo AV. Inhibition of penicillin transport from the cerebrospinal fluid after intracisternal inoculation of bacteria. J Clin Invest 1974; 54:316-25.
25. Mathison JC, Virca GD, Wolfson E, Tobias PS, Glaser K, Ulevitch RJ. Adaptation to bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages. J Clin Invest 1990; 85:1108-18.
26. Espevik T, Nissen-Meyer J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic/tumor necrosis factor from human monocytes. J Immunol Meth 1986; 95:99-105.
27. Arditi M, Ables L, Yogev R. Cerebrospinal fluid endotoxin levels in children with H. influenzae meningitis before and after administration of intravenous ceftriaxone. J Infect Dis 1989; 160:1005-11.
28. Berman NS, Siegel SE, Nachum R, Lipsey A, Leedom J. Cerebrospinal fluid endotoxin concentrations in gram-negative bacterial meningitis. J Pediatr 1976; 88:553-6.
29. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193:265-75.
30. Faggioni R, Fantuzzi G, Villa P, Buurman W, van Tits LJ, Ghezzi P. Independent down-regulation of central and peripheral tumor necrosis factor production as a result of lipopolysaccharide tolerance in mice. Infect Immun 1995; 63:1473-7.
31. Ernst JD, Decazes JM, Sande MA. Experimental pneumococcal meningitis: role of leukocytes in pathogenesis. Infect Immun 1983; 41:275-9.
32. Schultz MJ, Olszyna DP, de Jonge E, Verbon A, van Deventer SJ, PT. Reduced ex vivo chemokine production by polymorphonuclear cells after in vivo exposure of normal humans to endotoxin. J Infect Dis 2000; 182:1264-7.
33. Yagi Y, Shiono H, Shibahara T, Chikayama Y, Nakamura I, Ohnuma A. Increase in apoptotic polymorphonuclear neutrophils in peripheral blood after intramammary infusion of Escherichia coli lipopolysaccharide. Vet Immunol Immunopathol 2002; 89:115-25.
34. Grandel U, Grimminger F. Endothelial responses to bacterial toxins in sepsis. Crit Rev Immunol 2003; 23:267-99.
35. Peters K, Unger RE, Brunner J, Kirkpatrick CJ. Molecular basis of endothelial dysfunction in sepsis. Cardiovasc Res 2003; 60:49-57.
36. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348:138-50.
37. Lopez-Bojorquez LN, Dehesa AZ, Reyes-Teran G. Molecular mechanisms involved in the pathogenesis of septic shock. Arch Med 2004; 35:465-79.
38. Arditi M, Manogue KR, Caplan M, Yogev R. Cerebrospinal fluid cachectin/tumor necrosis factor-alpha and platelet-activating factor concentrations and severity of bacterial meningitis in children. J Infect Dis 1990; 162:139-47 [see comments].
39. Mustafa MM, Ramilo O, Olsen KD et al. Tumor necrosis factor in mediating experimental Haemophilus influenzae type B meningitis. J Clin Invest 1989; 84:1253-9.
40. Sharief MK, Ciardi M, Thompson EJ. Blood-brain barrier damage in patients with bacterial meningitis: association with tumor necrosis factor-alpha but not interleukin-1 beta. J Infect Dis 1992; 166:350-8.
41. Angstwurm K, Freyer D, Dirnagl U et al. Tumour necrosis factor alpha induces only minor inflammatory changes in the central nervous system, but augments experimental meningitis. Neuroscience 1998; 86:627-34.
42. Mushtaha AA, Schmalstieg FC, Hughes TK Jr, Rudloff HE, Goldman AS. Chemokinetic effects of exogenous and endogenous tumor necrosis factor alpha on human blood monocytes. Int Arch Allergy Appl Immunol 1989; 90:11-5.
43. Schmidt H, Stuertz K, Brück W et al. Intravenous granulocyte colony-stimulating factor increases the release of tumour necrosis factor and interleukin-1beta into the cerebrospinal fluid, but does not inhibit the growth of Streptococcus pneumoniae in experimental meningitis. Scand J Immunol 1999; 49:481-6.
44. Tauber MG, Sachdeva M, Kennedy SL, Loetscher H, Lesslauer W. Toxicity in neuronal cells caused by cerebrospinal fluid from pneumococcal and gram-negative meningitis. J Infect Dis 1992; 166:1045-50.
45. Gerber J, Bottcher T, Hahn M, Siemer A, Bunkowski S, Nau R. Increased mortality and spatial memory deficits in TNF-alpha-deficient mice in ceftriaxone-treated experimental pneumococcal meningitis. Neurobiol Dis 2004; 16:133-8.
46. Patrick D, Betts J, Frey EA, Prameya R, Dorovini-Zis K, Finlay BB. Haemophilus influenzae lipopolysaccharide disrupts confluent monolayers of bovine brain endothelial cells via a serumdependent cytotoxic pathway. J Infect Dis 1992; 165:865-72.
47. Østergaard C, Yieng-Kow RV, Benfield T, Frimodt-Møller N, Espersen F, Lundgren JD. Inhibition of leukocyte entry into the brain by the selectin-blocker, fucoidin decreases interleukin (IL)-1 levels, but increases IL-8 levels in cerebrospinal fluid during experimental pneumococcal meningitis in rabbits. Infect Immun 2000; 68:3153-7.
48. Tauber MG, Borschberg U, Sande MA. Influence of granulocytes on brain edema, intracranial pressure, and cerebrospinal fluid concentrations of lactate and protein in experimental meningitis. J Infect Dis 1988; 157:456-64.
49. Steinshamn S, Waage A. Lack of endotoxin tolerance with respect to TNF alpha production in the subarachnoid space. APMIS 2000; 108:107-12.
50. Pier GB, Markham RB, Eardley D. Correlation of the biologic responses of C3H/HEJ mice to endotoxin with the chemical and structural properties of the lipopolysaccharides from Pseudomonas aeruginosa and Escherichia coli. J Immunol 1981; 127:184-91.
51. Teghanemt A, Zhang D, Levis EN, Weiss JP, Gioannini TL. Molecular basis of reduced potency of underacylated endotoxins. J Immunol 2005; 175:4669-76.
52. Martin M, Katz J, Vogel SN, Michalek SM. Differential induction of endotoxin tolerance by lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli. J Immunol 2001; 167:5278-85.
53. Bingen E, Lambert-Zechovsky N, Mariani-Kurkdjian P et al. Bacterial counts in cerebrospinal fluid of children with meningitis. Eur J Clin Microbiol Infect Dis 1990; 9:278-81.
54. La Scolea LJ, Dryja D. Quantitation of bacteria in cerebrospinal fluid and blood of children with meningitis and its diagnostic significance. J Clin Microbiol 1984; 19:187-90.
55. van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004; 351:1849-59.